Literature DB >> 21865670

Diagnostic value of the nuclear matrix protein 22 test and urine cytology in upper tract urothelial tumors.

M Jovanovic1, I Soldatovic, A Janjic, A Vuksanovic, Z Dzamic, M Acimovic, J Hadzi-Djokic.   

Abstract

OBJECTIVE: To investigate the diagnostic value of the nuclear matrix protein 22 (NMP22) test in comparison to urine cytology for the detection of upper tract urothelial carcinoma. PATIENTS AND METHODS: Patients with transitional cell carcinoma of the upper urinary tract (n = 34) and patients with renal calculosis (n = 25) were included in this study. Voided urine samples and separated catheter urine specimens were assayed for NMP22 and cytological examination.
RESULTS: The sensitivity of the NMP22 test in separated and voided urine was 73.2 and 70.5%, respectively, compared to 64.7 and 58.8% of urine cytology. The specificity of the NMP22 test in separated and voided urine was 88 and 92%, respectively, compared to 96 and 96% of urine cytology. The combination of separated and voided urine is the best method because the sensitivity is 79.41% and specificity 88%. There is a high agreement of the NMP22 test in voided and separated urine (kappa = 0.795, p < 0.01), indicating that the voided urine is adequate for diagnosis.
CONCLUSIONS: The NMP22 test has higher sensitivity but lower specificity than cytology. The combination of these two tests could be a very useful diagnostic method for detection of upper urothelial tumors.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865670     DOI: 10.1159/000330246

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  11 in total

Review 1.  [Urine cytology - update 2013. A systematic review of recent literature].

Authors:  M Böhm; F vom Dorp; M Schostak; O W Hakenberg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

Review 2.  Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.

Authors:  David R Yates; James W F Catto
Journal:  World J Urol       Date:  2012-09-18       Impact factor: 4.226

3.  In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors.

Authors:  Enis Coskuner; Ibrahim Cevik; Alp Ozkan; Ozdal Dillioglugil; Atıf Akdas
Journal:  Int Urol Nephrol       Date:  2012-02-28       Impact factor: 2.370

Review 4.  Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis.

Authors:  Fabian Sanchis-Gomar; Alejandro Lucia; Thomas Yvert; Ana Ruiz-Casado; Helios Pareja-Galeano; Alejandro Santos-Lozano; Carmen Fiuza-Luces; Nuria Garatachea; Giuseppe Lippi; Claude Bouchard; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-21

5.  The role of urinary cytology when diagnostic workup is suspicious for upper tract urothelial carcinoma but tumour biopsy is nonconfirmatory.

Authors:  David Horovitz; Yifan Meng; Jean V Joseph; Changyong Feng; Guan Wu; Hani Rashid; Edward M Messing
Journal:  Can Urol Assoc J       Date:  2017-07-11       Impact factor: 1.862

6.  Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder?

Authors:  Simone Bier; Jörg Hennenlotter; Michael Esser; Sarah Mohrhardt; Steffen Rausch; Christian Schwentner; Moritz Maas; Susanne Deininger; Simon Walz; Jens Bedke; Arnulf Stenzl; Tilman Todenhöfer
Journal:  Dis Markers       Date:  2018-01-30       Impact factor: 3.434

7.  Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma.

Authors:  Chang-Sheng Xia; Chun-Hong Fan; Ming Su; Qing-Song Wang; Hui-Zhang Bao
Journal:  Dis Markers       Date:  2020-05-08       Impact factor: 3.434

8.  Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.

Authors:  Yujiro Hayashi; Kazutoshi Fujita; Kyosuke Matsuzaki; Makoto Matsushita; Norihiko Kawamura; Yoko Koh; Kosuke Nakano; Cong Wang; Yu Ishizuya; Yoshiyuki Yamamoto; Kentaro Jingushi; Taigo Kato; Atsunari Kawashima; Takeshi Ujike; Akira Nagahara; Motohide Uemura; Ryoichi Imamura; Tetsuya Takao; Shingo Takada; George J Netto; Norio Nonomura
Journal:  Cancer Sci       Date:  2019-04-07       Impact factor: 6.716

9.  An ensemble approach of urine sediment image analysis and NMP22 test for detection of bladder cancer cells.

Authors:  Eun-Jung Cho; Chang Kwon Bang; Hyunjung Kim; Hae Kyung Lee
Journal:  J Clin Lab Anal       Date:  2020-07-10       Impact factor: 2.352

10.  Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Masato Yanagi; Tsutomu Hamasaki; Jun Akatsuka; Yuki Endo; Hayato Takeda; Yukihiro Kondo
Journal:  BMC Urol       Date:  2021-12-02       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.